This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Ucl Business Plc. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Samuel Janes - Innovator in Cancer Biomarkers
Introduction
Samuel Janes is a notable inventor based in Harpenden, GB. He has made significant contributions to the field of cancer research, particularly in identifying biomarkers that can aid in cancer treatment. His innovative work focuses on enhancing the understanding of cell death in cancer cells.
Latest Patents
Samuel Janes holds a patent related to a cell death biomarker. This invention pertains to the identification of cancer cells that are sensitive to death receptor ligand (DRL)-induced cell death. The patent also encompasses prognostic methods and kits designed to identify these sensitive cancer cells. Furthermore, it includes novel compositions and therapeutic methods that utilize these compositions for effective cancer treatment. He has 1 patent to his name.
Career Highlights
Samuel Janes is associated with UCL Business Plc, where he continues to work on innovative solutions in cancer research. His career is marked by a commitment to advancing medical science and improving patient outcomes through his inventions.
Collaborations
He collaborates with esteemed colleagues such as Ultan McDermott and Neelam Kumar, contributing to a dynamic research environment focused on cancer therapies.
Conclusion
Samuel Janes is a pioneering inventor whose work in cancer biomarkers holds promise for improving treatment strategies. His contributions are vital in the ongoing battle against cancer, showcasing the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
